User:Mr. Ibrahem/Fingolimod

Fingolimod, sold under the brand name Gilenya, is a medication, mostly used to treat multiple sclerosis (MS). It reduces relapses in relapsing-remitting MS by approximately one-half over a two-year period. It may also be used for chronic inflammatory demyelinating polyneuropathy. It is taken by mouth.

Common side effects include headache, liver problems, diarrhea, nausea, cough, and pain. Other side effects may include AV block, infection, allergic reactions, skin cancer, lung problems, progressive multifocal leukoencephalopathy, and posterior reversible encephalopathy syndrome. Use in pregnancy may harm the baby. It is a sphingosine-1-phosphate receptor modulator, which prevents T cells from travelling from lymph nodes to the brain and spinal cord.

Fingolimod was approved for medical use in the United States in 2010 and Europe in 2011. In the United Kingdom 4 weeks of treatment costs the NHS about £1,470 as of 2021. This amount in the United States costs about 8,300 USD. A generic version was approved in 2021 in the USA.